Adenoviral-mediated gene transfer induces sustained pericardial VEGF expression in dogs:: effect on myocardial angiogenesis

被引:80
作者
Lazarous, DF [1 ]
Shou, M [1 ]
Stiber, JA [1 ]
Hodge, E [1 ]
Thirumurti, V [1 ]
Gonçalves, L [1 ]
Unger, EF [1 ]
机构
[1] NHLBI, Expt Physiol & Pharmacol Sect, Cardiol Branch, NIH, Bethesda, MD 20892 USA
关键词
collateral circulation; coronary circulation; gene therapy; growth factors; ischemia;
D O I
10.1016/S0008-6363(99)00203-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Angiogenic peptides like VEGF (vascular endothelial growth factor) and bFGF (basic fibroblast growth factor) have entered clinical trials for coronary artery disease. Attempts are being made to devise clinically relevant means of delivery and to effect site-specific delivery of these peptides to the cardiac tissue, in order to limit systemic side-effects. We characterized the response of the pericardium to delivery of a replication-deficient adenovirus carrying the cDNA for AdCMV.VEGF(165), and assessed the effect of pericardial VEGF(165) on myocardial collateral development in a canine model of progressive coronary occlusion. Methods: Ameroid constrictors were placed on the proximal left circumflex coronary artery of mongrel dogs. Ten days later, 6x10(9) pfu AdCMV.VEGF(165) (n=9, AdRSV.beta-gal (n=9), or saline (n=7) were injected through an indwelling pericardial catheter. Transfection efficiency was assessed by X-gal staining. Pericardial and serum VEGF levels were measured serially by ELISA. Maximal myocardial collateral perfusion was quantified with radiolabeled or fluorescent microspheres 28 days after treatment. Results: In AdRSV.beta-gal-treated dogs, there was extensive beta-gal staining in the pericardium and epicardium, with minimal beta-gal staining in the mid-myocardium and endocardium. Pericardial delivery of AdCMV.VEGF(165) resulted in sustained (8-14 day) pericardial transgene expression, with VEGF levels peaking 3 days after infection (>200 ng/ml) and decreasing; thereafter. There was no detectable increase in serum VEGF levels. Maximal collateral perfusion, a principal correlate of collateral development and angiogenesis, was equivalent in all groups. Conclusion: Adenoviral-mediated gene transfer is capable of inducing sustained VEGF(165) expression in the pericardium; however, locally targeted pericardial VEGF delivery failed to improve myocardial collateral perfusion in this model. (C) 1999 Published by Elsevier Science B.V. All rights reserved.
引用
收藏
页码:294 / 302
页数:9
相关论文
共 37 条
  • [1] SUPPRESSION OF RETINAL NEOVASCULARIZATION IN-VIVO BY INHIBITION OF VASCULAR ENDOTHELIAL GROWTH-FACTOR (VEGF) USING SOLUBLE VEGF-RECEPTOR CHIMERIC PROTEINS
    AIELLO, LP
    PIERCE, EA
    FOLEY, ED
    TAKAGI, H
    CHEN, H
    RIDDLE, L
    FERRARA, N
    KING, GL
    SMITH, LEH
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (23) : 10457 - 10461
  • [2] SYNERGISTIC EFFECT OF VASCULAR ENDOTHELIAL GROWTH-FACTOR AND BASIC FIBROBLAST GROWTH-FACTOR ON ANGIOGENESIS IN-VIVO
    ASAHARA, T
    BAUTERS, C
    ZHENG, LP
    TAKESHITA, S
    BUNTING, S
    FERRARA, N
    SYMES, JF
    ISNER, JM
    [J]. CIRCULATION, 1995, 92 (09) : 365 - 371
  • [3] Asahara Takayuki, 1996, Journal of the American College of Cardiology, V27, p1A
  • [4] Austin G E, 1993, Am J Cardiovasc Pathol, V4, P352
  • [5] ANGIOGENIC-INDUCED ENHANCEMENT OF COLLATERAL BLOOD-FLOW TO ISCHEMIC MYOCARDIUM BY VASCULAR ENDOTHELIAL GROWTH-FACTOR IN DOGS
    BANAI, S
    JAKLITSCH, MT
    SHOU, M
    LAZAROUS, DF
    SCHEINOWITZ, M
    BIRO, S
    EPSTEIN, SE
    UNGER, EF
    [J]. CIRCULATION, 1994, 89 (05) : 2183 - 2189
  • [6] SITE-SPECIFIC THERAPEUTIC ANGIOGENESIS AFTER SYSTEMIC ADMINISTRATION OF VASCULAR ENDOTHELIAL GROWTH-FACTOR
    BAUTERS, C
    ASAHARA, T
    ZHENG, LP
    TAKESHITA, S
    BUNTING, S
    FERRARA, N
    SYMES, JF
    ISNER, JM
    [J]. JOURNAL OF VASCULAR SURGERY, 1995, 21 (02) : 314 - 325
  • [7] PHYSIOLOGICAL ASSESSMENT OF AUGMENTED VASCULARITY INDUCED BY VEGF IN ISCHEMIC RABBIT HINDLIMB
    BAUTERS, C
    ASAHARA, T
    ZHENG, LP
    TAKESHITA, S
    BUNTING, S
    FERRARA, N
    SYMES, JF
    ISNER, JM
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 1994, 267 (04): : H1263 - H1271
  • [8] VEGF(121), A VASCULAR ENDOTHELIAL GROWTH-FACTOR (VEGF) ISOFORM LACKING HEPARIN-BINDING ABILITY, REQUIRES CELL-SURFACE HEPARAN SULFATES FOR EFFICIENT BINDING TO THE VEGF RECEPTORS OF HUMAN-MELANOMA CELLS
    COHEN, T
    GITAYGOREN, H
    SHARON, R
    SHIBUYA, M
    HALABAN, R
    LEVI, BZ
    NEUFELD, G
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (19) : 11322 - 11326
  • [9] DULBECCO E, 1980, VIROLOGY, P881
  • [10] DIRECT IN-VIVO GENE-TRANSFER INTO PORCINE MYOCARDIUM USING REPLICATION-DEFICIENT ADENOVIRAL VECTORS
    FRENCH, BA
    MAZUR, W
    GESKE, RS
    BOLLI, R
    [J]. CIRCULATION, 1994, 90 (05) : 2414 - 2424